Estrogen Receptor on the move: Cistromic plasticity and its implications in breast cancer
Autor: | Wilbert Zwart, Isabel Mayayo-Peralta, Stefan Prekovic |
---|---|
Přispěvatelé: | Chemical Biology |
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Cell signaling Clinical Biochemistry Estrogen receptor Breast Neoplasms Breast Neoplasms/genetics Biology SDG 3 – Goede gezondheid en welzijn Biochemistry Cell Line 03 medical and health sciences Breast cancer Transcriptional regulation 0302 clinical medicine SDG 3 - Good Health and Well-being Kinase signaling Cell Line Tumor Receptors medicine Humans Molecular Biology Transcription factor Neoplastic Tumor Chromatin binding Estrogen Receptor alpha/genetics Estrogen Receptor alpha Cancer General Medicine medicine.disease Estrogen Gene Expression Regulation Neoplastic 030104 developmental biology Receptors Estrogen ESR1 mutants Gene Expression Regulation Cistrome 030220 oncology & carcinogenesis Cancer research Molecular Medicine Steroid hormone receptor crosstalk Female Cistromic plasticity |
Zdroj: | Molecular Aspects of Medicine, 78:100939. Elsevier |
ISSN: | 0098-2997 |
Popis: | Estrogen Receptor (ERα) is a hormone-driven transcription factor, critically involved in driving tumor cell proliferation in the vast majority of breast cancers (BCas). ERα binds the genome at cis-regulatory elements, dictating the expression of a large spectrum of responsive genes in 3D genomic space. While initial reports described a rather static ERα chromatin binding repertoire, we now know that ERα DNA interactions are highly versatile, altered in breast tumor development and progression, and deviate between tumors from patients with differential outcome. Multiple cellular signaling cascades are known to impinge on ERα genomic function, changing its cistrome to retarget the receptor to other regions of the genome and reprogram its impact on breast cell biology. This review describes the current state-of-the-art on which factors manipulate the ERα cistrome and how this alters the response to both endogenous and exogenous hormonal stimuli, ultimately impacting BCa cell progression and response to commonly used therapeutic interventions. Novel insights in ERα cistrome dynamics may pave the way for better patient diagnostics and the development of novel therapeutic interventions, ultimately improving cancer care and patient outcome. |
Databáze: | OpenAIRE |
Externí odkaz: |